The research, led by Mengyuan Jing, Haoxiang Lu, and Qing Liu with colleagues at Lanzhou University Second Hospital, the Guangdong Cardiovascular Institute, and partner institutions, set out to build an explainable machine learning model that could predict functional improvement after ablation in patients with atrial fibrillation combined with heart failure. Rather than relying on a single measurement, the team fused three complementary streams of information: the geometry of the left atrium and pulmonary veins as seen on cardiac CT angiography, quantitative radiomics features extracted from the left atrial wall, and a handful of routine clinical variables. The result was a combined model, dubbed COMB, that achieved an area under the receiver operating characteristic curve of 0.866 in the training set, 0.803 in the validation set, and 0.845 in an independent testing set drawn from other hospitals.

Those numbers deserve unpacking, because the area under the curve, or AUC, is the workhorse metric for judging how well a model separates patients who will improve from those who will not. A value of 0.5 would mean the model performs no better than a coin flip, while 1.0 would indicate perfect discrimination. Scores consistently above 0.80 across three separate patient cohorts, including an external test set the model had never encountered during development, represent solid, clinically meaningful performance. Equally important is how the team arrived at that performance. Patients from the primary institution were randomly divided into training and validation sets in a seven-to-three ratio, while two other organizations contributed entirely separate testing cohorts, a design that guards against the model simply memorizing the quirks of one hospital’s scanner or patient population.

The technical heart of the study lies in what the researchers chose to measure. Cardiac CT angiography, already a routine part of pre-ablation planning because it maps the pulmonary veins before catheter insertion, provides exquisitely detailed three-dimensional images of the left atrium, the chamber where fibrillation typically originates. From these images the team extracted morphological features describing the shape of the left atrium and the pulmonary veins, capturing subtle geometric signatures such as chamber distortion and remodeling that a human reader might overlook. In parallel, they applied radiomics, a computational approach that converts medical images into hundreds of quantitative descriptors of texture, intensity, and spatial pattern, to the left atrial wall itself, the thin muscular sleeve where ablation lesions are created and where fibrotic change often determines whether the procedure succeeds.

From this high-dimensional feature space, the researchers distilled two focused models. Two shape features and three left atrial wall radiomics features survived rigorous screening and were used to construct what they called the Shape model and the Wall model, respectively. Each model produced a continuous score, the Shape_score and the Wall_score, which quantified how strongly a given patient’s cardiac anatomy resembled that of patients who went on to improve. These scores were then integrated with the clinical variables that proved most informative, namely gender, hyperlipidemia, blood urea level, and the type of atrial fibrillation, to yield the final combined model. The parsimony is striking: out of the vast number of features that could have been included, the final predictor rests on just a handful of imaging and clinical inputs, all obtainable from examinations and blood tests that are already standard practice.

What elevates the study beyond a typical prediction exercise is its commitment to explainability. Black-box algorithms have long been a stumbling block for clinical adoption, because physicians are understandably reluctant to act on a probability they cannot interrogate. The researchers addressed this by applying SHAP, or Shapley additive explanations, a technique borrowed from cooperative game theory that assigns each input feature a precise contribution to every individual prediction. In effect, SHAP reveals which factors pushed a particular patient’s predicted probability up or down, and by aggregating these contributions across the cohort, the team identified the features with the greatest impact on outcomes in both the Shape and Wall models. This transparency allows a cardiologist to see, for example, whether an unfavorable prediction stems from pronounced atrial remodeling, abnormal wall texture suggesting fibrosis, or a clinical factor such as persistent rather than paroxysmal fibrillation.

The clinical stakes of this kind of tool are considerable. Patients with atrial fibrillation and concomitant heart failure represent a particularly vulnerable group, and ablation in these individuals carries procedural risk, substantial cost, and a demanding recovery. If a model can reliably flag patients unlikely to experience functional improvement, clinicians could counsel them more honestly, weigh alternative management strategies such as optimized medical therapy, or reserve ablation for those with the greatest expected benefit. Conversely, identifying patients with a high predicted probability of improvement could support earlier referral and shared decision-making grounded in quantitative evidence rather than clinical intuition alone. Because the model’s inputs come from CT angiography and routine laboratory work, it could in principle be deployed without any additional testing beyond what pre-ablation workups already include.

The multicenter architecture of the study strengthens its claims in another important way. Models trained and tested within a single institution often flatter themselves, absorbing center-specific artifacts in scanner protocol, image reconstruction, and patient mix. By including 240 patients in the training set, 101 in the validation set, and 75 in external testing sets from two other organizations, the team demonstrated that the model’s discrimination held up across different hospitals and imaging environments. The ethics committees of all three participating institutions approved the retrospective study, and the requirement for individual informed consent was waived because of its retrospective design, with the work conducted in accordance with the Declaration of Helsinki.

The authors themselves are careful about the limits of what they have shown. The study was retrospective, meaning it looked backward at patients who had already undergone ablation rather than prospectively assigning the model to guide care in real time. The team explicitly states that further prospective evaluation is required before the model can be implemented clinically, a caveat that applies to nearly every prediction algorithm now emerging in cardiovascular medicine. Prospective validation would involve using the COMB model to generate predictions before ablation and then tracking whether those predictions match observed outcomes, ideally across diverse populations and healthcare systems. Questions about calibration, the agreement between predicted probabilities and actual event rates, and about how the model behaves in subgroups underrepresented in the data, would also need answers.

Even with those caveats, the study offers a compelling glimpse of where cardiac imaging and artificial intelligence are converging. The same CT scan obtained to map a patient’s pulmonary veins becomes, through shape analysis and radiomics, a quantitative portrait of atrial health, and machine learning converts that portrait, together with a few clinical facts, into an individualized forecast of recovery. The SHAP framework keeps the forecast auditable, showing clinicians exactly which anatomical and biological signals drove the conclusion. For the millions of patients whose fibrillation and heart failure travel together, and for the physicians deciding whether to offer them ablation, a tool that turns pre-procedural images into evidence-based expectations could reshape the conversation, replacing uncertainty with a number that both doctor and patient can understand, question, and trust.

Subject of Research: Explainable machine learning on cardiac CT angiography to predict functional improvement after atrial fibrillation ablation in patients with heart failure

Article Title: Explainable machine learning model based on cardiac CT angiography for predicting functional improvement after atrial fibrillation ablation: a multicenter study

Article References: Jing, M., Lu, H., Liu, Q., Jing, Y., Lei, F., Yang, X., Chen, G., Xi, H., Xin, W., Zhu, H., Sun, Q., Zhang, Y., Ren, J., Ren, W., Liu, Z., Wang, G., & Zhou, J. (2026). Explainable machine learning model based on cardiac CT angiography for predicting functional improvement after atrial fibrillation ablation: a multicenter study. BMC Medical Imaging. https://doi.org/10.1186/s12880-026-02822-1

Image Credits: AI Generated

DOI: 10.1186/s12880-026-02822-1

Keywords: atrial fibrillation, heart failure, catheter ablation, cardiac CT angiography, machine learning, radiomics, left atrium, SHAP explainability, predictive modeling, multicenter study, BMC Medical Imaging, cardiac imaging